Exelixis (EXEL) Gains from Investment Securities (2010 - 2026)

Exelixis (EXEL) recorded quarterly Gains from Investment Securities of $34.2 million in Q2 2026, up 162.48% quarter-over-quarter from -$54.8 million in Q1 2026, and up 52.03% on a YoY basis from $22.5 million in Q2 2025.

Exelixis (EXEL) Gains from Investment Securities (2010 - 2026) Analysis & Trends

Exelixis' Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $34.2 million for Q2 2026.

  • In Q2 2026, Gains from Investment Securities rose 52.03% year-over-year to $34.2 million; the TTM figure through Apr 2026 stood at $23.3 million (down 87.46% YoY), while the FY2026 annual figure was $11.6 million, down 93.19% from the prior year.
  • Gains from Investment Securities was $34.2 million for Q2 2026 at Exelixis, up from -$54.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $161.2 million in Q1 2025 to a low of -$54.8 million in Q1 2026.
  • Historically, Gains from Investment Securities has averaged $15.1 million across 5 years, with a median of $6.5 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities slumped 400.5% in 2024, then jumped 3543.73% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $7.2 million in 2022, then plunged by 38.62% to $4.4 million in 2023, then tumbled by 237.08% to -$6.1 million in 2024, then soared by 1019.52% to $55.8 million in 2025, then sank by 38.63% to $34.2 million in 2026.
  • The last three Gains from Investment Securities figures came in at $34.2 million (Q2 2026), -$54.8 million (Q1 2026), and $55.8 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Exelixis 13.61 Bn 12.83 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 34.23 Mn
Apr 3, 2026 34.23 Mn
Jan 2, 2026 -54.79 Mn
Jan 2, 2026 -54.79 Mn
Oct 3, 2025 55.78 Mn
Oct 3, 2025 55.78 Mn
Jul 4, 2025 -11.90 Mn
Jul 4, 2025 -11.90 Mn
Apr 4, 2025 22.52 Mn
Apr 4, 2025 22.52 Mn
Jan 3, 2025 161.24 Mn
Jan 3, 2025 161.24 Mn
Sep 27, 2024 -6.07 Mn
Sep 27, 2024 -6.07 Mn
Jun 28, 2024 8.33 Mn
Jun 28, 2024 8.33 Mn
Mar 29, 2024 6.99 Mn
Mar 29, 2024 6.99 Mn
Dec 29, 2023 4.43 Mn
Dec 29, 2023 4.43 Mn